[{"id":"0850e024-8b63-48dd-9e35-e28737bab106","acronym":"","url":"https://clinicaltrials.gov/study/NCT04976660","created_at":"2021-07-26T17:53:24.225Z","updated_at":"2024-07-02T16:36:11.176Z","phase":"Phase 1/2","brief_title":"TT-4 as a Single Agent in Subjects With Advanced Selected Solid Tumors","source_id_and_acronym":"NCT04976660","lead_sponsor":"Tarus Therapeutics, Inc.","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PORT-7"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 69","initiation":"Initiation: 12/15/2022","start_date":" 12/15/2022","primary_txt":" Primary completion: 06/01/2023","primary_completion_date":" 06/01/2023","study_txt":" Completion: 09/30/2023","study_completion_date":" 09/30/2023","last_update_posted":"2022-05-02"}]